- Rakesh Jain
Dr. Rakesh K. Jain is the Andrew Werk Cook Professor of Tumor Biology at
Massachusetts General Hospitalin the Harvard Medical School. Dr. Jain primarily researches tumor pathophysiology. His work on cancer therapies led to discovery of an alternate use of Herceptin, an anti-tumor cell pharmaceutical compound produced by Genentech, as an inhibitor for blood vesselgrowth necessary for tumor growth. [ [http://query.nytimes.com/gst/fullpage.html?sec=health&res=9A04EFDA1038F932A15750C0A9649C8B63&n=Top%2fReference%2fTimes%20Topics%2fOrganizations%2fH%2fHarvard%20University%20 Study Said to Show Added Benefit of Genentech Breast Cancer Drug] . Andrew Pollack. New York Times. Retrieved January 17, 2007.] His award-winning work on tumor biology has been recognized by a number of professional recognitions, including the following awards in 2006:
* Distinguished Service Award, Nature Biotechnology-Miami Symposium on Angiogenesis
* Outstanding Achievement Award, Society of American Asian Scientists in Cancer Research
* Robert L. Krigel Lecture, Fox Chase Cancer Center, Philadelphia
* Alpha Chi Sigma Research Award, American Institute of Chemical Engineers
* Benjamin Zweifach Distinguished Lecture, The City College, New York
Dr. Jain received his B.Tech. degree from the
Indian Institutes of Technologyin Chemical Engineeringin 1972 and received his M.Ch.E. and Ph.D. in Chemical Engineering from the University of Delawarein 1974 and 1976, respectively.
* [http://steele.mgh.harvard.edu/cv/rakesh.html Curriculum Vitae] at Harvard Medical School
Wikimedia Foundation. 2010.